Tonix Pharmaceuticals Holding (TNXP) Shares Issued (2016 - 2026)

Tonix Pharmaceuticals Holding's Shares Issued history runs 11 years deep, the most recent figure standing at $235074.0 for Q1 2026.

• On a quarterly basis, Shares Issued rose 13076.79% year-over-year to $235074.0 in Q1 2026; TTM through Mar 2026 was $235074.0, a 13076.79% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 29668.46% from the prior year.
• Shares Issued declined to $235074.0 in Q1 2026 per TNXP's latest filing, from $1.2 million in the prior quarter.
• Across five years, Shares Issued topped out at $11.2 million in Q1 2022 and bottomed at $435.0 in Q4 2022.
• The 5-year median for Shares Issued is $248656.0 (2023), against an average of $1.1 million.
• Biggest YoY gain for Shares Issued was 29668.46% in 2025; the steepest drop was 99.69% in 2025.
• Year by year, Shares Issued stood at $435.0 in 2022, then soared by 77.93% to $774.0 in 2023, then soared by 399.35% to $3865.0 in 2024, then jumped by 29668.46% to $1.2 million in 2025, then tumbled by 79.57% to $235074.0 in 2026.
• Per Business Quant, the three latest TNXP Shares Issued figures stand at $235074.0 (Q1 2026), $1.2 million (Q4 2025), and $2686.0 (Q3 2025).